The world's first AI-based lung cancer decision support software
Our platform helps clinicians to identify and track at-risk patients and to speed up interventions for patients with cancer while reducing unnecessary invasive procedures.
WHAT WE DO
We are a lung health company,
developing products to help clinicians in the management, diagnosis and care of patients.
WHO WE ARE
A team of award-winning machine learning, medical device and clinical experts who work with top hospitals, physicians and authors of lung cancer guidelines across Europe and US.
HOW WE CAN
HELP YOU
Optellum has gathered the largest real-world dataset of CT scans and, using Artificial Intelligence and Machine Learning, developed a solution to enable clinicians to identify at-risk patients and to guide lung cancer management.
Latest News and events
-
Optellum expands its commercial team in readiness for US sales
-
Optellum set to take off in 2021 according to Business Insider
-
Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer
-
Optellum partners with University of Oxford in £11 million AI programme to accelerate lung cancer diagnosis
Partners
